Mrs Lillian Mary Mccumber, MS-SLP | |
1004 Hancock Rd, Bullhead City, AZ 86442-5946 | |
(928) 758-6871 | |
(928) 758-6834 |
Full Name | Mrs Lillian Mary Mccumber |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1004 Hancock Rd, Bullhead City, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336272467 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | #SLPL4986 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Lillian Mary Mccumber, MS-SLP 414 Oatman Ave, Kingman, AZ 86401-6168 Ph: (928) 758-6871 | Mrs Lillian Mary Mccumber, MS-SLP 1004 Hancock Rd, Bullhead City, AZ 86442-5946 Ph: (928) 758-6871 |
News Archive
With efforts to pass a national health care bill at a stalemate in Washington, two newspaper explore some of the options. The New York Times reports: "As Republicans and Democrats claim to be searching for common ground in the health care debate, one idea that lawmakers on both sides seem to agree on is that health insurance should be sold across state lines.
A selection of health policy stories from Massachusetts, Oregon, Kansas and North Carolina.
"Missouri law now contains a direct challenge to the federal health care law passed earlier this year. Primary voters approved Proposition C by a wide margin Tuesday. ... The measure is intended to invalidate in Missouri a key element of the federal health care law passed by Congress and signed by President Barack Obama in March. That law requires individuals to purchase health insurance beginning in 2014."
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Magnetic stimulation of the brain improves working memory, offering a new potential avenue of therapy for individuals living with Alzheimer's disease and other forms of dementia, according to new research from the Duke University School of Medicine.
› Verified 5 days ago
Mrs. Carolyn A. Muecke, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2585 Miracle Mile Road, Unit #124, Bullhead City, AZ 86442 Phone: 928-763-4030 |